Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesGerresheimer AG

Gerresheimer AG

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2026-10-28T03:28:18.628853Z
Market Cap
2480.60M

Momentum Score

…

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
14.98
Low
65.90
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Gerresheimer AG makes specialty glass and precision plastic primary packaging and drug-delivery systems for pharmaceutical and healthcare customers. Long-term growth could be supported by rising demand for injectable and biologic therapies, greater use of prefilled and sterile packaging, and the company's global manufacturing and regulatory footprint.
Key risks include customer concentration, regulatory and quality compliance failures, and sensitivity to raw material, energy and currency volatility that may strain margins or disrupt production.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
32.75
Dividend Yield
6.60%
Revenue TTM
2250.26M
Revenue Per Share
65.15
Gross Profit TTM
605.15M
Debt / Equity
0.95
ROE
1.81%
Net Debt
-
ROCE
9.15%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Income before tax - - 135.15M 98.17M 107.20M
Net income - - 88.56M 80.78M 128.97M
Selling general administrative - - 233.38M 233.28M 221.47M
Gross profit - - 437.61M 388.04M 400.13M
Ebit 186.49M 154.03M 153.16M 115.09M 141.40M
Operating income - - 156.46M 123.76M 139.46M
Other operating expenses 12.66M 2.04M 2.80M 0.22M 0.67M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Tax provision - - 45.26M 15.49M 29.57M
Interest income - - 17.69M 19.07M 27.31M
Extraordinary items - - - - 53.50M
Income tax expense 38.62M 40.62M 45.26M 15.49M -23.93M
Total revenue - - 1418.79M 1392.26M 1367.73M
Cost of revenue - - 981.18M 1004.22M 967.60M
Net income applicable to common shares 96.12M 83.79M 88.56M 80.78M 128.97M
Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Total assets - - 2616.57M 2641.24M 2730.91M
Intangible assets - - 632.09M 685.02M 835.09M
Other current assets 21.04M 19.81M 15.14M 8.71M 7.21M
Total liab - - 1732.74M 1716.14M 1858.25M
Total stockholder equity - - 883.83M 925.10M 872.66M
Deferred long term liab 69.85M 54.35M 38.46M 20.56M 25.13M
Other current liab 89.94M 60.23M 48.48M 98.26M 224.83M
Common stock 31.40M 31.40M 31.40M 31.40M 31.40M
Retained earnings 614.48M 538.72M 473.76M 427.44M 394.58M
Other liab 298.21M 281.67M 301.61M 311.83M 394.72M
Good will - - 642.31M 672.16M 670.59M
Other assets 414.13M 281.66M 253.47M 221.09M 168.38M
Cash - - 87.95M 85.83M 80.57M
Total current liabilities 1101.43M 885.78M 578.00M 890.80M 768.35M
Short long term debt total - - 836.40M 498.17M 751.42M
Other stockholder equity 83.22M -90.10M -135.15M -47.56M -67.14M
Property plant equipment 858.72M 696.66M 570.32M 534.62M 509.42M
Total current assets 810.14M 657.18M 551.37M 544.84M 571.86M
Net tangible assets -4.64M -240.57M -352.11M -411.51M -607.89M
Net receivables 359.60M 280.49M 253.23M 260.48M 307.96M
Long term debt - - 809.60M 490.28M 747.75M
Inventory 310.71M 238.27M 189.98M 185.09M 171.49M
Accounts payable 356.79M 284.25M 211.62M 221.45M 207.28M
Breakdown 2023-11-30 2022-11-30 2021-11-30 2020-11-30 2019-11-30
Type yearly yearly yearly yearly yearly
Date 2023-11-30 2022-11-30 2021-11-30 2020-11-30 2019-11-30
Change to liabilities - 63.92M 50.67M -4.15M -153.04M
Total cashflows from investing activities - -256.18M -197.04M -157.03M -203.21M
Net borrowings - 83.96M 42.08M -13.05M 38.12M
Total cash from financing activities - 44.24M 8.03M -52.15M -1.07M
Change to operating activities - - - - -17.58M
Net income 116.13M 96.12M 83.79M 88.56M 80.78M
Change in cash - 14.55M 25.19M 7.29M -10.83M
Total cash from operating activities - 221.94M 212.08M 222.19M 192.92M
Depreciation - 169.24M 142.46M 141.97M 150.64M
Other cashflows from investing activities - 0.34M 9.45M 16.98M 5.23M
Dividends paid - 39.25M 39.25M 39.31M 39.41M
Change to inventory - -66.45M -44.85M -12.17M -12.89M
Change to account receivables - -44.99M 3.49M -9.81M 44.27M
Other cashflows from financing activities - -0.47M 5.20M 0.21M 0.22M
Change to netincome - 1.91M -25.62M 16.07M 98.19M
Capital expenditures 0.00M 256.53M 206.48M 174.11M 164.55M
Change in working capital - - - -71.31M -177.18M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Klaus-Bungert-Strasse 4, Düsseldorf, Germany, 40468

49 211 61 81 00

https://www.gerresheimer.com

13535

Name Title Year Born
Mr. Dietmar Siemssen CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board 1963
Dr. Bernd Metzner Ph.D. CFO & Member of the Management Board 1970
Dr. Lukas Burkhardt Member of the Management Board 1979
Ms. Katja Schnitzler Member of Supervisory Board 1981
Ms. Carolin Nadilo Corp. Director of Investor Relations NA
Ueli Utzinger Group Sr. Director Marketing & Communication NA
Mr. Helmut Schweiger MD & GM of Gerresheimer Horsovsky Tyn Plant NA
Ms. Katja Schnitzler Global Senior VP of People & Organization and Member of Supervisory Board 1981
Mr. Uwe Ferdinand Röehrhoff Chairman of the Management Board & CEO 1962
Mr. Wolf Uwe Lehmann CFO & Member of the Management Board 1971

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.08
+24.11%
HG
CAD 3.95
+14.49%
PPTA
CAD 26.70
+13.57%
HUT
CAD 70.83
+10.07%
KEEL
CAD 2.54
+9.27%
TSU
CAD 29.84
-29.32%
PXT
CAD 20.26
-14.66%
IFP
CAD 12.83
-12.90%
WEED
CAD 0.86
-9.47%
BDGI
CAD 74.97
-5.95%

Equity Sectors*

  • Basic Materials

    +1.73%

  • Communication Services

    +0.71%

  • Consumer Cyclical

    +0.07%

  • Consumer Defensive

    +0.58%

  • Energy

    +1.23%

  • Financial Services

    -0.21%

  • Healthcare

    +1.32%

  • Industrials

    +0.07%

  • Real Estate

    -0.26%

  • Technology

    +0.98%

  • Utilities

    +0.78%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…